Future aspects of pharmacological treatment to inhibit the allergic march

Pediatric Allergy and Immunology, Supplement

Volumn 12, Issue 14, 2001, Pages 102-107

  Warner, J O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Antihistamines; Asthma; Atopic dermatitis; Prevention

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; STEROID;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; DRUG MECHANISM; FAMILY HISTORY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0034998111     PISSN: 09065784     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2001.121422.x     Document Type: Conference Paper

References (32)

1. OSWALD H, PHELAN PD, LANNIGAN A, et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 1997: 23: 14-20.
2. GERRITSEN J, KOETER GH, POSTMA DS, et al. Airway responsiveness in childhood as a predictor of outcome of asthma in adulthood. Amer Rev Respir Dis 1991: 143: 1468-72.
3. BEASLEYR,ROCHE WR, ROBERTS JA, HOLGATEST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989: 139: 806-17.
4. LAITINEN LH, HEINO M, LAITINEN A, et al. Damage to the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985: 131: 599-606.
5. WARNER JO. Bronchial hyperresponsiveness, atopy, airway inflammation and asthma. Pediatr Allergy Immunol 1998: 9: 56-60.
6. SONT JK, HAM J, VAN KRIEKEN JM, et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996: 51: 496-502.
7. YOUNG S, LE SOUEF PN, GEELHOED GC, et al. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991: 324: 1168-73.
8. LE SOUEF P. Infant lung function, bronchial responsiveness and the development of asthma. Pediatr Allergy Immunol 2000: 11 (suppl 13): 15-18.
9. SALOB S, ATHERTON D. Prevalence of respiratory symptoms in children with atopic dermatitis attending pediatric dermatology clinics. Pediatrics 1993: 91: 8-12.
10. KULIG M, BERGMANN R, TACKE V, et al. Long lasting sensitization to food during the first two years precedes allergic airway disease. Pediatr Allergy Immunol 1998: 9: 61-7.
11. ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double blind randomised placebo controlled trial. First results of ETAC. Pediatr Allergy Immunol 1998: 9: 116-24.
12. ANDERSON HR, POTTIER AC, STRACHAN DP. Asthma from birth to age 23: incidence and relationship to prior and concurrent atopic disease. Thorax 1992: 47: 537-42.
13. CRONER S, KJELLMAN N-IM. Development of atopic disease in relation to family history and cord blood IgE levels - 11 year follow-up in 1654 children. Pediatr Allergy Immunol 1990: 1: 14-21.
14. DELACOURT C, LABBE D, VASSAULT A, et al. Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma. Acta Paediatr Scand 1994: 49: 843-7.
15. BERGMANN RL, BERGMANN KE, WAHN U. Can we predict atopic disease using perinatal risk factors? Clin Exp Allergy 1998: 28: 905-7.
16. IIKURA Y, NASPITZ CK, MIKAWA H, et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992: 68: 233-6.
17. BUSTOS GJ, BUSTOS D, BUSTOS GJ, ROMERO O. Prevention of asthma with ketotifen in pre-asthmatic children; a 3 year follow-up study. Clin Exp Allergy 1995: 25:568-73.
18. SIMONS FER. Prospective long term safety evaluation of the HI receptor antagonist, cetirizine, in very young children with atopic dermatitis. J Allergy Clin Immunol 1999: 104:433-40.
19. CIPRANDI G, PASSALACQUA G, CANONICA GW. Effect of HI antihistamines on adhesion molecules; a possible rationale for long term treatment. Clin Exp Allergy 1999: 29 (suppl 3): 49-53.
20. GWALTNEY JM, DRUCE HM. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin Infect Dis 1997: 25: 1188-94.
21. MARGUET C, JOUEN-BOEDES F, DEAN TP, WARNER JO. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough or cystic fibrosis. Am J Respir Crit Care Med 1999: 159: 1533-40.
22. HOSHINO M, NAKAMURA Y. The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. Eur Respir J 1997: 10: 858-65.
23. LOH RKS, JABARA HH, GEHA RS. Sodium cromoglycate inhibits Sμ←-ε deletional switch recombination and IgE synthesis in human B cells. J Exp Med 1994: 180: 663-71.
24. CHUNG KF. Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy. Eur Respir J 1995: 8: 1203-13.
25. KNORR B, MATZ J, BURNSTEIN JA, et al. Montelukast for chronic asthma in 6-14 year old children. JAMA 1998: 279: 1181-6.
26. REICIN A, WHITE R, WEINSTEIN SF, et al. Montelukast, a leukotriene receptor antagonist, in combination with loratidine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 2000: 160: 2481-8.
27. AGERTOFT L, PEDERSEN S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994: 88: 373-81.
28. PEDERSEN S, WARNER JO, PRICE JF. Early use of inhaled steroids in children with asthma. Clin Exp Allergy 1997: 27: 995-1006.
29. KLEBL FH, WEBER G, KALDEN JR, NUSSLEIN HG. In vitro and in vivo effects of corticosteroids on IgE and IgG subclass secretion. Clin Exp Allergy 1994: 24: 1022-9.
30. ZIPG G, LACK G, HARBECK RJ, et al. The in vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol 1994: 94: 222-30.
31. REIJONEN TM, KORPPI M. One-year follow-up of young children hospitalised for wheezing; the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr Pulmonol 1998: 26: 113-19.
32. The Childhood Asthma Management Program Research Group. Long term effects of budesonide or nedromil in children with asthma. N Engl J Med 2000: 343: 1054-63.